Avandia to get new heart warning label
Avandia, the prescription drug used to control diabetes in many U.S. patients, will have a new warning label affixed soon.The problem is, the message may be more confusing than helpful. The U.S. government stated this week that the new warning label specifically for Avandia will say that the drug may or may not increase the risk of heart attacks. That's comforting.
The FDA concluded that studies on the drug, so far, are very contradictory and an ardent 'heart attack warning' label was not justified. Without further research, it looks like patient confusion on Avandia will only continue to escalate. If you're on the drug, do you feel safe?
Actos, the diabetes drug, has a weird set of warnings. The drug can cut the risk of heart attack, stroke and death -- but at the same time, a similar drug (Avandia) raises the risk of heart failure. What on earth is going on here?
After months and months of scares and media coverage on the possible heart risks of taking the diabetes drug Avandia, a "black box" warning will soon come to that drug's packaging.
There seems to be quite a bit of news about the negative side effects of many prescription drugs these days, but do these drugs help more people than they hurt?
Avandia has been
European pharmaceutical giant Sanofi is
Avandia has
Another day, another warning from a prescription drug. GlaxoSmithKline's "Avandia" diabetes drug (aka, rosiglitazone) is being hailed as raising the risk of a heart attack and heart death by 43% and 64%, respectively, when taken for diabetes treatment.











